Mometasona Ratiopharm (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasona Ratiopharm, is a corticosteroid presented as a nasal spray for endosinusial use. It acts locally to decrease inflammatory cytokine production in the nasal mucosa, providing relief from symptoms such as nasal congestion, sneezing and itching associated with allergic rhinitis and other nasal inflammatory disorders.

GNH USA supplies Mometasona Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory‑approved batches to meet global demand.

Mometasone furoate nasal spray is a topical corticosteroid used to manage inflammatory conditions of the nasal passages. - Allergic rhinitis: reduces nasal congestion, sneezing and itching associated with seasonal or perennial allergies. - Nasal polyps: shrinks polyp size and improves nasal airflow in patients with chronic nasal polyposis. - Non‑allergic rhinitis: alleviates nasal irritation and discharge not caused by allergens. - Post‑operative nasal inflammation: helps decrease swelling and crusting after nasal surgery.

Mometasone furoate nasal spray may cause local and systemic adverse reactions.

Common Side Effects: - Nasal irritation or burning sensation. - Epistaxis (nosebleeds). - Headache. - Altered taste or oral dryness.

Serious or Rare Side Effects: - Adrenal suppression with prolonged high‑dose use. - Ocular effects such as cataracts or glaucoma. - Opportunistic fungal infection of the nasal passages. - Severe allergic reaction (anaphylaxis). - Nasal septum perforation (rare).

Before using Mometasona Ratiopharm, consider the following precautions. - Pregnancy: consult a healthcare provider; risk‑benefit assessment is required. - Pediatric use: safety not established for children under two years of age. - Active nasal infection: avoid use until infection is resolved. - Long‑term therapy: monitor for signs of systemic corticosteroid exposure. - Drug interactions: avoid concomitant use with systemic corticosteroids without medical supervision. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Mometasone furoate nasal spray can interact with other medications.

Major Interactions (Avoid): - Systemic corticosteroids: increased risk of systemic glucocorticoid effects. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise systemic exposure.

Moderate Interactions (Monitor Closely): - Antihistamines: may mask local irritation symptoms. - Other intranasal agents (e.g., antifungal sprays): potential additive irritation. - Live vaccines: systemic absorption could attenuate immune response.